Pills by jugaad: Excerpts from Bottle of Lies

A new investigative book, Bottle of Lies, says that Indian cancer drugs are contaminated; cholesterol medication has shards of glass; and, blood …

Colour code for generic medicines a no-brainer

There are a number of systemic gaps without addressing which the government’s latest plan for the pharma sector won’t work

A Patient's Dilemma

Doctors continue to push for branded medications, after the government's launch of an affordable medicine campaign, at the expense of their …

Government stand against EU ban on Indian drugs much needed, says industry

Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU

When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

Six reasons why antibiotics access remains a challenge in Uganda

Lack of registry, sub-standard health facilities, poor cold storage, limited expenditure on health, irrational antibiotic use and lack of …

Look back at the decade: Generic drugs

Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts

COVID-19 also brings focus back on pollution due to pharmaceuticals

No time for quick-fix measures. India needs stricter laws  

Pills for polls

The free medicine scheme in Rajasthan may benefit Congress

Activists demand compulsory licence for another life-saving cancer drug

Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Vidarbha gets its first generic medicines shop

Challenge to popularising these stores is to get doctors to prescribe low-cost generic drugs

EU fines nine pharma companies for violating competition rules

Lundbeck pharma made other companies enter market late with generic versions of its drug citalopram

European Parliament rejects Anti-Counterfeiting Trade Agreement

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries

US keeps India out of Priority Foreign Country list of 'worst IP offenders'

US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests

Substantiate allegations against Ranbaxy, says Supreme Court

Experts say allegations against the generic pharma company motivated by vested interests

‘PESTICIDES’ IN DRUGS

Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too

Novartis loses patent appeal in landmark suit

Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …